Clinical trials
Active, not recruiting Cardiomyopathies trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2010 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 4 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lexeo Therapeutics | 2 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Alnylam Pharmaceuticals | 1 |
| Scripps Translational Science Institute | 1 |
| St. Jude Children's Research Hospital | 1 |
| Tenaya Therapeutics | 1 |
| The Cleveland Clinic | 1 |
| University of Pennsylvania | 1 |
| University of Rochester | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiomyopathies | 10 |
| Cardiomyopathy, Dilated | 2 |
| Heart Failure | 2 |
| Amyloidosis | 1 |
| Amyloidosis, Familial | 1 |
| Aortic Valve Stenosis | 1 |
| Arrhythmogenic Right Ventricular Dysplasia | 1 |
| Atrial Fibrillation | 1 |
| Cardiomyopathy, Hypertrophic | 1 |
| Cardiomyopathy, Restrictive | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.